Rank | Gene Set | Z-score |
---|---|---|
1 | omega-hydroxylase P450 pathway (GO:0097267) | 7.87694470 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.51611539 |
3 | L-phenylalanine catabolic process (GO:0006559) | 7.51611539 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.18566766 |
5 | L-phenylalanine metabolic process (GO:0006558) | 7.18566766 |
6 | aromatic amino acid family catabolic process (GO:0009074) | 6.74454159 |
7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.48793118 |
8 | * uronic acid metabolic process (GO:0006063) | 6.42272624 |
9 | * glucuronate metabolic process (GO:0019585) | 6.42272624 |
10 | * drug metabolic process (GO:0017144) | 6.16386748 |
11 | indole-containing compound catabolic process (GO:0042436) | 6.05129672 |
12 | indolalkylamine catabolic process (GO:0046218) | 6.05129672 |
13 | tryptophan catabolic process (GO:0006569) | 6.05129672 |
14 | kynurenine metabolic process (GO:0070189) | 5.94153679 |
15 | bile acid biosynthetic process (GO:0006699) | 5.86883761 |
16 | oxidative demethylation (GO:0070989) | 5.78674509 |
17 | tryptophan metabolic process (GO:0006568) | 5.70764795 |
18 | high-density lipoprotein particle remodeling (GO:0034375) | 5.70141270 |
19 | urea cycle (GO:0000050) | 5.69399805 |
20 | urea metabolic process (GO:0019627) | 5.69399805 |
21 | glyoxylate metabolic process (GO:0046487) | 5.65487335 |
22 | alpha-linolenic acid metabolic process (GO:0036109) | 5.64631050 |
23 | negative regulation of fibrinolysis (GO:0051918) | 5.57588318 |
24 | regulation of fibrinolysis (GO:0051917) | 5.35508541 |
25 | protein carboxylation (GO:0018214) | 5.35273407 |
26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.35273407 |
27 | sulfur amino acid catabolic process (GO:0000098) | 5.35020216 |
28 | cysteine metabolic process (GO:0006534) | 5.30916436 |
29 | daunorubicin metabolic process (GO:0044597) | 5.25093477 |
30 | polyketide metabolic process (GO:0030638) | 5.25093477 |
31 | doxorubicin metabolic process (GO:0044598) | 5.25093477 |
32 | nitrogen cycle metabolic process (GO:0071941) | 5.23010147 |
33 | phenylpropanoid metabolic process (GO:0009698) | 5.18096248 |
34 | bile acid metabolic process (GO:0008206) | 5.12724614 |
35 | complement activation, alternative pathway (GO:0006957) | 5.11569236 |
36 | regulation of protein activation cascade (GO:2000257) | 5.09698276 |
37 | regulation of cholesterol esterification (GO:0010872) | 5.09293319 |
38 | serine family amino acid catabolic process (GO:0009071) | 5.08743108 |
39 | reverse cholesterol transport (GO:0043691) | 4.94312512 |
40 | aromatic amino acid family metabolic process (GO:0009072) | 4.90205930 |
41 | regulation of triglyceride catabolic process (GO:0010896) | 4.88816014 |
42 | protein-lipid complex remodeling (GO:0034368) | 4.87735672 |
43 | macromolecular complex remodeling (GO:0034367) | 4.87735672 |
44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.87735672 |
45 | homocysteine metabolic process (GO:0050667) | 4.83221228 |
46 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.83096360 |
47 | tyrosine metabolic process (GO:0006570) | 4.77762647 |
48 | negative regulation of protein activation cascade (GO:2000258) | 4.77341596 |
49 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.74079627 |
50 | regulation of complement activation (GO:0030449) | 4.73409715 |
51 | negative regulation of sterol transport (GO:0032372) | 4.73333981 |
52 | negative regulation of cholesterol transport (GO:0032375) | 4.73333981 |
53 | phospholipid efflux (GO:0033700) | 4.72297000 |
54 | ethanol metabolic process (GO:0006067) | 4.67444725 |
55 | amino-acid betaine metabolic process (GO:0006577) | 4.65404307 |
56 | triglyceride homeostasis (GO:0070328) | 4.62653929 |
57 | acylglycerol homeostasis (GO:0055090) | 4.62653929 |
58 | alpha-amino acid catabolic process (GO:1901606) | 4.61845335 |
59 | * flavonoid metabolic process (GO:0009812) | 4.58656584 |
60 | lysine catabolic process (GO:0006554) | 4.56308984 |
61 | lysine metabolic process (GO:0006553) | 4.56308984 |
62 | S-adenosylmethionine metabolic process (GO:0046500) | 4.56244628 |
63 | bile acid and bile salt transport (GO:0015721) | 4.49702140 |
64 | cellular ketone body metabolic process (GO:0046950) | 4.49311368 |
65 | alkaloid metabolic process (GO:0009820) | 4.47804505 |
66 | plasma lipoprotein particle clearance (GO:0034381) | 4.45449089 |
67 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.36529397 |
68 | cholesterol efflux (GO:0033344) | 4.35235175 |
69 | glycine metabolic process (GO:0006544) | 4.35137276 |
70 | drug catabolic process (GO:0042737) | 4.32901201 |
71 | imidazole-containing compound metabolic process (GO:0052803) | 4.31513097 |
72 | indolalkylamine metabolic process (GO:0006586) | 4.29216112 |
73 | regulation of humoral immune response (GO:0002920) | 4.27590622 |
74 | coenzyme catabolic process (GO:0009109) | 4.26209858 |
75 | cellular amino acid catabolic process (GO:0009063) | 4.24805906 |
76 | glutamate metabolic process (GO:0006536) | 4.21904226 |
77 | opsonization (GO:0008228) | 4.21194388 |
78 | amine catabolic process (GO:0009310) | 4.20121204 |
79 | cellular biogenic amine catabolic process (GO:0042402) | 4.20121204 |
80 | plasma lipoprotein particle assembly (GO:0034377) | 4.15077033 |
81 | serine family amino acid metabolic process (GO:0009069) | 4.12005684 |
82 | low-density lipoprotein particle remodeling (GO:0034374) | 4.11576202 |
83 | cytolysis (GO:0019835) | 4.08817471 |
84 | arginine metabolic process (GO:0006525) | 4.02449017 |
85 | cellular modified amino acid catabolic process (GO:0042219) | 4.02073350 |
86 | hormone catabolic process (GO:0042447) | 4.01484141 |
87 | ethanol oxidation (GO:0006069) | 4.01395927 |
88 | negative regulation of hemostasis (GO:1900047) | 3.98933904 |
89 | negative regulation of blood coagulation (GO:0030195) | 3.98933904 |
90 | fibrinolysis (GO:0042730) | 3.98053451 |
91 | serine family amino acid biosynthetic process (GO:0009070) | 3.97259635 |
92 | regulation of plasminogen activation (GO:0010755) | 3.96924679 |
93 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.95696633 |
94 | aldehyde catabolic process (GO:0046185) | 3.94853813 |
95 | * benzene-containing compound metabolic process (GO:0042537) | 3.90314975 |
96 | * acute-phase response (GO:0006953) | 3.90094115 |
97 | ketone body metabolic process (GO:1902224) | 3.88874049 |
98 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.88242407 |
99 | positive regulation of lipid catabolic process (GO:0050996) | 3.86065486 |
100 | negative regulation of lipase activity (GO:0060192) | 3.85717110 |
101 | regulation of bile acid biosynthetic process (GO:0070857) | 3.85223015 |
102 | primary alcohol catabolic process (GO:0034310) | 3.84141130 |
103 | cholesterol homeostasis (GO:0042632) | 3.82816024 |
104 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.82659725 |
105 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.82659725 |
106 | negative regulation of complement activation (GO:0045916) | 3.81556980 |
107 | blood coagulation, intrinsic pathway (GO:0007597) | 3.80693975 |
108 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.78194269 |
109 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.78194269 |
110 | phospholipid homeostasis (GO:0055091) | 3.77930705 |
111 | sterol homeostasis (GO:0055092) | 3.76498296 |
112 | drug transmembrane transport (GO:0006855) | 3.74875243 |
113 | organic acid catabolic process (GO:0016054) | 3.74605755 |
114 | carboxylic acid catabolic process (GO:0046395) | 3.74605755 |
115 | exogenous drug catabolic process (GO:0042738) | 3.73596508 |
116 | heme transport (GO:0015886) | 3.73530941 |
117 | short-chain fatty acid metabolic process (GO:0046459) | 3.73302671 |
118 | protein-lipid complex assembly (GO:0065005) | 3.72573226 |
119 | epoxygenase P450 pathway (GO:0019373) | 3.71585840 |
120 | plasma lipoprotein particle organization (GO:0071827) | 3.71481315 |
121 | regulation of cholesterol homeostasis (GO:2000188) | 3.67524136 |
122 | negative regulation of wound healing (GO:0061045) | 3.65032657 |
123 | negative regulation of coagulation (GO:0050819) | 3.64917746 |
124 | * xenobiotic metabolic process (GO:0006805) | 3.64374955 |
125 | protein activation cascade (GO:0072376) | 3.62889992 |
126 | intestinal cholesterol absorption (GO:0030299) | 3.60974227 |
127 | acetyl-CoA metabolic process (GO:0006084) | 3.60892738 |
128 | complement activation (GO:0006956) | 3.60786015 |
129 | * cellular glucuronidation (GO:0052695) | 3.59922040 |
130 | complement activation, classical pathway (GO:0006958) | 3.59879432 |
131 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.54106897 |
132 | response to nitrosative stress (GO:0051409) | 3.53707867 |
133 | lipoprotein metabolic process (GO:0042157) | 3.52548637 |
134 | sodium-independent organic anion transport (GO:0043252) | 3.39060470 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.37648592 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.16559826 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.95864422 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.50574456 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.27832343 |
6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.03017657 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.89118888 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.02587392 |
9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.84848689 |
10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.43435750 |
11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08768164 |
12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.03222326 |
13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8744624 |
14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.99545933 |
15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94821664 |
16 | VDR_22108803_ChIP-Seq_LS180_Human | 1.91884650 |
17 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.77878435 |
18 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.67882503 |
19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.64404905 |
20 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62230993 |
21 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.57951225 |
22 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.57901007 |
23 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.56485937 |
24 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.52563794 |
25 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.51979404 |
26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.49537168 |
27 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.47867297 |
28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.45756159 |
29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45434239 |
30 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.44505582 |
31 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.43312832 |
32 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.42349368 |
33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.40384188 |
34 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.39401125 |
35 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.38274568 |
36 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.31396497 |
37 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.29657504 |
38 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.29657504 |
39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28957995 |
40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.27599812 |
41 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.27214504 |
42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24008391 |
43 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.19860137 |
44 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.19679513 |
45 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.19679513 |
46 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.19080678 |
47 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.18973680 |
48 | STAT3_23295773_ChIP-Seq_U87_Human | 1.18900056 |
49 | P300_19829295_ChIP-Seq_ESCs_Human | 1.18491901 |
50 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.18434512 |
51 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.17157026 |
52 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.15163916 |
53 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.14991397 |
54 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.14335042 |
55 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.13960459 |
56 | NFYA_21822215_ChIP-Seq_K562_Human | 1.13539850 |
57 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.12581091 |
58 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.10909930 |
59 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.10909930 |
60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10901928 |
61 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.10846001 |
62 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.10371145 |
63 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.08861217 |
64 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.08650793 |
65 | AR_25329375_ChIP-Seq_VCAP_Human | 1.06538158 |
66 | TCF4_23295773_ChIP-Seq_U87_Human | 1.05706507 |
67 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05514760 |
68 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05036083 |
69 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.04044680 |
70 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03957984 |
71 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.03633832 |
72 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.03100220 |
73 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02170731 |
74 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.00518703 |
75 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.00345332 |
76 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.00033734 |
77 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.99113531 |
78 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.98887293 |
79 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98585794 |
80 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.97808199 |
81 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.97112036 |
82 | NFYB_21822215_ChIP-Seq_K562_Human | 0.96968532 |
83 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.96889260 |
84 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.96535272 |
85 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.93782923 |
86 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93417653 |
87 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.92811590 |
88 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92329034 |
89 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.91494688 |
90 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.91376100 |
91 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.90867523 |
92 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.90745466 |
93 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.90377495 |
94 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90235968 |
95 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84863361 |
96 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82766034 |
97 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.82610756 |
98 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82423262 |
99 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81061658 |
100 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.77727211 |
101 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.77462564 |
102 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76648079 |
103 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.76177865 |
104 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75271245 |
105 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74718188 |
106 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73581890 |
107 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71081893 |
108 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.70626386 |
109 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70223410 |
110 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68796661 |
111 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.66888602 |
112 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.65497563 |
113 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65398651 |
114 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65398651 |
115 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.64127493 |
116 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.62988755 |
117 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62884318 |
118 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62646570 |
119 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61216447 |
120 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59887354 |
121 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.59600614 |
122 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55723453 |
123 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54906838 |
124 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.54783652 |
125 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.54308044 |
126 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53626503 |
127 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51981281 |
128 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51826987 |
129 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51109161 |
130 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50054343 |
131 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49596994 |
132 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48927163 |
133 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.48125515 |
134 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.47862843 |
135 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.47681704 |
136 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.47600408 |
137 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.47599441 |
138 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.45178717 |
139 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.45072941 |
140 | GATA1_19941826_ChIP-Seq_K562_Human | 0.45045895 |
141 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45040256 |
142 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44810224 |
143 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44151520 |
144 | GATA2_19941826_ChIP-Seq_K562_Human | 0.44130186 |
145 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.43958748 |
146 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.43022569 |
147 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.42674276 |
148 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41494471 |
149 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41133154 |
150 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.39843163 |
151 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.39655536 |
152 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.39161140 |
153 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.38483625 |
154 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.37289246 |
155 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37131106 |
156 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.35861199 |
157 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.35122637 |
158 | NCOR_22424771_ChIP-Seq_293T_Human | 0.35090484 |
159 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.34978091 |
160 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34277537 |
161 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.34178734 |
162 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.34077471 |
163 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.33930803 |
164 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.33618933 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.32582293 |
2 | MP0005360_urolithiasis | 7.59626605 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.45058520 |
4 | MP0005365_abnormal_bile_salt | 6.17585936 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.38588780 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.08878825 |
7 | MP0003252_abnormal_bile_duct | 3.91444060 |
8 | MP0010329_abnormal_lipoprotein_level | 3.58878825 |
9 | MP0009840_abnormal_foam_cell | 3.34658360 |
10 | MP0005083_abnormal_biliary_tract | 3.05332653 |
11 | MP0003195_calcinosis | 2.79236994 |
12 | MP0005332_abnormal_amino_acid | 2.73320192 |
13 | MP0001666_abnormal_nutrient_absorption | 2.69312925 |
14 | MP0003191_abnormal_cellular_cholesterol | 2.26068137 |
15 | MP0004019_abnormal_vitamin_homeostasis | 2.17051301 |
16 | MP0000609_abnormal_liver_physiology | 2.15085512 |
17 | MP0002118_abnormal_lipid_homeostasis | 2.09554652 |
18 | MP0002138_abnormal_hepatobiliary_system | 1.91784554 |
19 | MP0003868_abnormal_feces_composition | 1.90408957 |
20 | MP0005319_abnormal_enzyme/_coenzyme | 1.80836741 |
21 | MP0001764_abnormal_homeostasis | 1.65428842 |
22 | MP0009697_abnormal_copulation | 1.58865384 |
23 | MP0005451_abnormal_body_composition | 1.56663960 |
24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54776488 |
25 | MP0003011_delayed_dark_adaptation | 1.40366184 |
26 | MP0003656_abnormal_erythrocyte_physiolo | 1.24058667 |
27 | MP0009643_abnormal_urine_homeostasis | 1.23350297 |
28 | MP0003186_abnormal_redox_activity | 1.21013106 |
29 | MP0003705_abnormal_hypodermis_morpholog | 1.16444822 |
30 | MP0000598_abnormal_liver_morphology | 1.15839677 |
31 | MP0000604_amyloidosis | 1.07475997 |
32 | MP0005647_abnormal_sex_gland | 1.06719076 |
33 | MP0009764_decreased_sensitivity_to | 1.05476152 |
34 | MP0002254_reproductive_system_inflammat | 1.04919192 |
35 | MP0009763_increased_sensitivity_to | 0.99909462 |
36 | MP0005636_abnormal_mineral_homeostasis | 0.91506718 |
37 | MP0010368_abnormal_lymphatic_system | 0.87678554 |
38 | MP0005551_abnormal_eye_electrophysiolog | 0.87406216 |
39 | MP0008469_abnormal_protein_level | 0.86815990 |
40 | MP0009642_abnormal_blood_homeostasis | 0.86440217 |
41 | MP0005408_hypopigmentation | 0.83953218 |
42 | MP0005187_abnormal_penis_morphology | 0.83216674 |
43 | MP0003879_abnormal_hair_cell | 0.80049674 |
44 | MP0009765_abnormal_xenobiotic_induced | 0.79394626 |
45 | MP0005670_abnormal_white_adipose | 0.78636085 |
46 | MP0005376_homeostasis/metabolism_phenot | 0.78452525 |
47 | MP0006036_abnormal_mitochondrial_physio | 0.78436273 |
48 | MP0004147_increased_porphyrin_level | 0.78246548 |
49 | MP0002078_abnormal_glucose_homeostasis | 0.76544565 |
50 | MP0005084_abnormal_gallbladder_morpholo | 0.76321000 |
51 | MP0004043_abnormal_pH_regulation | 0.75842714 |
52 | MP0002132_abnormal_respiratory_system | 0.75597806 |
53 | MP0002876_abnormal_thyroid_physiology | 0.73765144 |
54 | MP0002971_abnormal_brown_adipose | 0.71730515 |
55 | MP0005334_abnormal_fat_pad | 0.67904365 |
56 | MP0004130_abnormal_muscle_cell | 0.67815328 |
57 | MP0009053_abnormal_anal_canal | 0.67574561 |
58 | MP0005220_abnormal_exocrine_pancreas | 0.67345123 |
59 | MP0003690_abnormal_glial_cell | 0.65535750 |
60 | MP0001661_extended_life_span | 0.65314002 |
61 | MP0001501_abnormal_sleep_pattern | 0.64905359 |
62 | MP0005535_abnormal_body_temperature | 0.64009927 |
63 | MP0005266_abnormal_metabolism | 0.63775730 |
64 | MP0003329_amyloid_beta_deposits | 0.62538017 |
65 | MP0001986_abnormal_taste_sensitivity | 0.61225236 |
66 | MP0001756_abnormal_urination | 0.60003361 |
67 | MP0000639_abnormal_adrenal_gland | 0.59184759 |
68 | MP0003183_abnormal_peptide_metabolism | 0.59134106 |
69 | MP0005448_abnormal_energy_balance | 0.58350327 |
70 | MP0002822_catalepsy | 0.57858658 |
71 | MP0005377_hearing/vestibular/ear_phenot | 0.57634891 |
72 | MP0003878_abnormal_ear_physiology | 0.57634891 |
73 | MP0005464_abnormal_platelet_physiology | 0.53992142 |
74 | MP0002282_abnormal_trachea_morphology | 0.53809374 |
75 | MP0006035_abnormal_mitochondrial_morpho | 0.53576573 |
76 | MP0009785_altered_susceptibility_to | 0.52221621 |
77 | MP0001485_abnormal_pinna_reflex | 0.49985246 |
78 | MP0003638_abnormal_response/metabolism_ | 0.48074193 |
79 | MP0008874_decreased_physiological_sensi | 0.47952708 |
80 | MP0005395_other_phenotype | 0.46899212 |
81 | MP0008873_increased_physiological_sensi | 0.46268694 |
82 | MP0002136_abnormal_kidney_physiology | 0.46230299 |
83 | MP0003718_maternal_effect | 0.45540516 |
84 | MP0004782_abnormal_surfactant_physiolog | 0.45072725 |
85 | MP0008872_abnormal_physiological_respon | 0.44838783 |
86 | MP0010386_abnormal_urinary_bladder | 0.44439461 |
87 | MP0005410_abnormal_fertilization | 0.43904329 |
88 | MP0003436_decreased_susceptibility_to | 0.42172525 |
89 | MP0004142_abnormal_muscle_tone | 0.42037774 |
90 | MP0005248_abnormal_Harderian_gland | 0.40983912 |
91 | MP0002928_abnormal_bile_duct | 0.40365121 |
92 | MP0003953_abnormal_hormone_level | 0.40243230 |
93 | MP0003724_increased_susceptibility_to | 0.40198962 |
94 | MP0002796_impaired_skin_barrier | 0.39939489 |
95 | MP0003075_altered_response_to | 0.38744327 |
96 | MP0005645_abnormal_hypothalamus_physiol | 0.38653456 |
97 | MP0005666_abnormal_adipose_tissue | 0.37642455 |
98 | MP0000427_abnormal_hair_cycle | 0.37088809 |
99 | MP0002837_dystrophic_cardiac_calcinosis | 0.36749789 |
100 | MP0000579_abnormal_nail_morphology | 0.35397503 |
101 | MP0005166_decreased_susceptibility_to | 0.35149680 |
102 | MP0009672_abnormal_birth_weight | 0.34998218 |
103 | MP0001243_abnormal_dermal_layer | 0.33737352 |
104 | MP0009115_abnormal_fat_cell | 0.33360876 |
105 | MP0000230_abnormal_systemic_arterial | 0.32741071 |
106 | MP0003633_abnormal_nervous_system | 0.32553611 |
107 | MP0000249_abnormal_blood_vessel | 0.32545024 |
108 | MP0004381_abnormal_hair_follicle | 0.32204527 |
109 | MP0003646_muscle_fatigue | 0.31321334 |
110 | MP0001853_heart_inflammation | 0.31277842 |
111 | MP0005386_behavior/neurological_phenoty | 0.31148446 |
112 | MP0004924_abnormal_behavior | 0.31148446 |
113 | MP0004883_abnormal_blood_vessel | 0.30896406 |
114 | MP0002102_abnormal_ear_morphology | 0.30880568 |
115 | MP0005646_abnormal_pituitary_gland | 0.29600467 |
116 | MP0001324_abnormal_eye_pigmentation | 0.29504115 |
117 | MP0002168_other_aberrant_phenotype | 0.29449956 |
118 | MP0002909_abnormal_adrenal_gland | 0.29136950 |
119 | MP0009745_abnormal_behavioral_response | 0.29059159 |
120 | MP0002970_abnormal_white_adipose | 0.28985189 |
121 | MP0001944_abnormal_pancreas_morphology | 0.28958702 |
122 | MP0006082_CNS_inflammation | 0.28841428 |
123 | MP0010234_abnormal_vibrissa_follicle | 0.28453186 |
124 | MP0009384_cardiac_valve_regurgitation | 0.28361153 |
125 | MP0001845_abnormal_inflammatory_respons | 0.28053652 |
126 | MP0001881_abnormal_mammary_gland | 0.27960095 |
127 | MP0000538_abnormal_urinary_bladder | 0.27539026 |
128 | MP0005167_abnormal_blood-brain_barrier | 0.27059579 |
129 | MP0002060_abnormal_skin_morphology | 0.26576909 |
130 | MP0004264_abnormal_extraembryonic_tissu | 0.25050186 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.41864744 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.38627286 |
3 | Intrahepatic cholestasis (HP:0001406) | 7.27861580 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.74102054 |
5 | Hypobetalipoproteinemia (HP:0003563) | 6.60389728 |
6 | Prolonged partial thromboplastin time (HP:0003645) | 6.55318120 |
7 | Xanthomatosis (HP:0000991) | 6.31615327 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.59810424 |
9 | Complement deficiency (HP:0004431) | 4.99571889 |
10 | Hypolipoproteinemia (HP:0010981) | 4.91178317 |
11 | Joint hemorrhage (HP:0005261) | 4.78159184 |
12 | Hyperammonemia (HP:0001987) | 4.64651116 |
13 | Epidermoid cyst (HP:0200040) | 4.59064030 |
14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.48526011 |
15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.40054233 |
16 | Abnormality of methionine metabolism (HP:0010901) | 4.33704308 |
17 | Hyperglycinemia (HP:0002154) | 4.32668749 |
18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.27770582 |
19 | Ketosis (HP:0001946) | 4.27340957 |
20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.25798920 |
21 | Hypoalphalipoproteinemia (HP:0003233) | 4.25051666 |
22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.19446760 |
23 | Fat malabsorption (HP:0002630) | 4.14631617 |
24 | Hyperglycinuria (HP:0003108) | 3.93615941 |
25 | Abnormality of glycine metabolism (HP:0010895) | 3.90005630 |
26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.90005630 |
27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.87278397 |
28 | Conjugated hyperbilirubinemia (HP:0002908) | 3.86634115 |
29 | Hypoglycemic coma (HP:0001325) | 3.85649491 |
30 | Hypercholesterolemia (HP:0003124) | 3.76831844 |
31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.71266604 |
32 | Abnormality of complement system (HP:0005339) | 3.64948333 |
33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.39439168 |
34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.34666496 |
35 | * Hyperbilirubinemia (HP:0002904) | 3.13561021 |
36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.09410300 |
37 | Delayed CNS myelination (HP:0002188) | 3.09367873 |
38 | Steatorrhea (HP:0002570) | 3.05963186 |
39 | Fair hair (HP:0002286) | 3.02993822 |
40 | Abnormality of serum amino acid levels (HP:0003112) | 3.02366338 |
41 | Ketoacidosis (HP:0001993) | 3.02307223 |
42 | Hepatocellular carcinoma (HP:0001402) | 2.96146879 |
43 | Spontaneous abortion (HP:0005268) | 2.93016269 |
44 | Myocardial infarction (HP:0001658) | 2.91105586 |
45 | Hypochromic microcytic anemia (HP:0004840) | 2.83675382 |
46 | Skin nodule (HP:0200036) | 2.82052744 |
47 | Metabolic acidosis (HP:0001942) | 2.80088920 |
48 | Acanthocytosis (HP:0001927) | 2.71765500 |
49 | Abnormality of purine metabolism (HP:0004352) | 2.70476251 |
50 | Vascular calcification (HP:0004934) | 2.62720056 |
51 | Lethargy (HP:0001254) | 2.61135631 |
52 | Dicarboxylic aciduria (HP:0003215) | 2.59667096 |
53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.59667096 |
54 | Glycosuria (HP:0003076) | 2.59103146 |
55 | Abnormality of urine glucose concentration (HP:0011016) | 2.59103146 |
56 | Systemic lupus erythematosus (HP:0002725) | 2.58021006 |
57 | Glomerulonephritis (HP:0000099) | 2.50412992 |
58 | Abnormal gallbladder morphology (HP:0012437) | 2.49117812 |
59 | Spastic diplegia (HP:0001264) | 2.47222272 |
60 | Hypoglycemic seizures (HP:0002173) | 2.46412159 |
61 | Cerebral edema (HP:0002181) | 2.42186199 |
62 | Cholelithiasis (HP:0001081) | 2.41930336 |
63 | Mitral stenosis (HP:0001718) | 2.37616326 |
64 | Irritability (HP:0000737) | 2.37160340 |
65 | Malnutrition (HP:0004395) | 2.36447208 |
66 | Gout (HP:0001997) | 2.35946355 |
67 | Abnormal gallbladder physiology (HP:0012438) | 2.35699092 |
68 | Cholecystitis (HP:0001082) | 2.35699092 |
69 | Cardiovascular calcification (HP:0011915) | 2.32888398 |
70 | Amyloidosis (HP:0011034) | 2.30053625 |
71 | Neonatal onset (HP:0003623) | 2.29941538 |
72 | Esophageal varix (HP:0002040) | 2.22583420 |
73 | Generalized hypopigmentation of hair (HP:0011358) | 2.22432748 |
74 | Gingival bleeding (HP:0000225) | 2.19296125 |
75 | Facial shape deformation (HP:0011334) | 2.19097479 |
76 | Potter facies (HP:0002009) | 2.19097479 |
77 | Menorrhagia (HP:0000132) | 2.17984010 |
78 | Brushfield spots (HP:0001088) | 2.16418701 |
79 | Late onset (HP:0003584) | 2.15281418 |
80 | Pancreatitis (HP:0001733) | 2.13251890 |
81 | Poikilocytosis (HP:0004447) | 2.12025707 |
82 | Osteomalacia (HP:0002749) | 2.11470931 |
83 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.08524604 |
84 | Sensorimotor neuropathy (HP:0007141) | 2.08458126 |
85 | Vomiting (HP:0002013) | 2.06270532 |
86 | Arthropathy (HP:0003040) | 2.05210133 |
87 | Joint swelling (HP:0001386) | 2.04737952 |
88 | Enlarged kidneys (HP:0000105) | 2.04737693 |
89 | Thrombophlebitis (HP:0004418) | 2.04210775 |
90 | Hyperphosphaturia (HP:0003109) | 2.04197263 |
91 | Generalized aminoaciduria (HP:0002909) | 2.03189574 |
92 | Abnormal biliary tract physiology (HP:0012439) | 2.01704404 |
93 | Bile duct proliferation (HP:0001408) | 2.01704404 |
94 | Abnormality of the gallbladder (HP:0005264) | 2.00572015 |
95 | Opisthotonus (HP:0002179) | 2.00039265 |
96 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99594860 |
97 | Hemorrhage of the eye (HP:0011885) | 1.98697868 |
98 | Hyperventilation (HP:0002883) | 1.97661554 |
99 | Rickets (HP:0002748) | 1.95757830 |
100 | Hydroxyprolinuria (HP:0003080) | 1.94636441 |
101 | Abnormality of proline metabolism (HP:0010907) | 1.94636441 |
102 | Hypothermia (HP:0002045) | 1.93891355 |
103 | Pulmonary embolism (HP:0002204) | 1.93197638 |
104 | Abnormal cartilage morphology (HP:0002763) | 1.92140438 |
105 | Abnormality of iron homeostasis (HP:0011031) | 1.90515514 |
106 | Alkalosis (HP:0001948) | 1.89368209 |
107 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87871968 |
108 | Reduced antithrombin III activity (HP:0001976) | 1.87225870 |
109 | Renal cortical cysts (HP:0000803) | 1.85421261 |
110 | Hypophosphatemic rickets (HP:0004912) | 1.84693995 |
111 | Elevated hepatic transaminases (HP:0002910) | 1.80691780 |
112 | Nephritis (HP:0000123) | 1.79876486 |
113 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79285108 |
114 | Abnormality of vitamin metabolism (HP:0100508) | 1.79228149 |
115 | Proximal tubulopathy (HP:0000114) | 1.76637100 |
116 | Reticulocytosis (HP:0001923) | 1.75941876 |
117 | Status epilepticus (HP:0002133) | 1.75421228 |
118 | Neonatal hypoglycemia (HP:0001998) | 1.71707409 |
119 | Increased serum ferritin (HP:0003281) | 1.70674212 |
120 | Widely patent fontanelles and sutures (HP:0004492) | 1.68126807 |
121 | Abnormality of alanine metabolism (HP:0010916) | 1.67401224 |
122 | Hyperalaninemia (HP:0003348) | 1.67401224 |
123 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.67401224 |
124 | Purpura (HP:0000979) | 1.67113305 |
125 | Abnormal urine phosphate concentration (HP:0012599) | 1.66801796 |
126 | Abnormality of the renal cortex (HP:0011035) | 1.65934054 |
127 | Blue irides (HP:0000635) | 1.63001166 |
128 | Elevated alkaline phosphatase (HP:0003155) | 1.57593616 |
129 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.53977435 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.05030799 |
2 | SIK1 | 4.57351561 |
3 | FGFR4 | 4.46323207 |
4 | ERN1 | 4.15490701 |
5 | ACVR1B | 4.09069779 |
6 | MAP4K2 | 3.12671361 |
7 | TAOK3 | 3.07917765 |
8 | INSRR | 3.01911404 |
9 | ADRBK2 | 2.86750476 |
10 | ERBB4 | 2.67052264 |
11 | PKN2 | 2.47928184 |
12 | MST1R | 2.39059875 |
13 | MAP2K4 | 2.31725951 |
14 | FLT3 | 2.01658754 |
15 | NUAK1 | 2.00084106 |
16 | CASK | 1.97680244 |
17 | OXSR1 | 1.86789608 |
18 | BMPR1B | 1.86336006 |
19 | WNK3 | 1.84432887 |
20 | MAPK11 | 1.83669804 |
21 | PIK3CG | 1.81856414 |
22 | FRK | 1.76502279 |
23 | TRIB3 | 1.76272043 |
24 | TYK2 | 1.69192034 |
25 | STK39 | 1.67616541 |
26 | LATS1 | 1.66918672 |
27 | DAPK2 | 1.58909856 |
28 | PTK6 | 1.57423879 |
29 | NTRK3 | 1.51176099 |
30 | ZAK | 1.47244775 |
31 | ABL2 | 1.45647838 |
32 | FGFR2 | 1.41000342 |
33 | IRAK1 | 1.34022133 |
34 | WNK4 | 1.33897361 |
35 | KDR | 1.33216750 |
36 | NEK9 | 1.31216569 |
37 | MAPK13 | 1.30952801 |
38 | MAP3K7 | 1.24114076 |
39 | GRK6 | 1.20731853 |
40 | JAK2 | 1.19268474 |
41 | PRKAA2 | 1.18721690 |
42 | MAP3K10 | 1.15601943 |
43 | NLK | 1.12396886 |
44 | MAP3K4 | 1.09657857 |
45 | FER | 1.07733898 |
46 | TBK1 | 1.06882299 |
47 | BCR | 1.06063697 |
48 | MAP2K3 | 1.06049722 |
49 | PINK1 | 1.05373138 |
50 | TXK | 1.04360478 |
51 | ERBB2 | 1.03672001 |
52 | MAPK4 | 1.01526398 |
53 | MAP3K14 | 0.98744627 |
54 | JAK1 | 0.98247528 |
55 | TLK1 | 0.95872553 |
56 | CAMKK2 | 0.94621526 |
57 | MET | 0.93787237 |
58 | PRKCE | 0.92683648 |
59 | PRKCZ | 0.92308844 |
60 | MAP3K3 | 0.89661333 |
61 | EPHB1 | 0.87466916 |
62 | MAP3K12 | 0.84498708 |
63 | STK38L | 0.82550016 |
64 | CDK6 | 0.81992705 |
65 | ADRBK1 | 0.81392346 |
66 | MAP3K11 | 0.79249709 |
67 | MAPK12 | 0.78789066 |
68 | MAP2K6 | 0.78768028 |
69 | PRKACG | 0.77542664 |
70 | RIPK1 | 0.77338740 |
71 | CSK | 0.75981946 |
72 | TNK2 | 0.74584866 |
73 | MAPK15 | 0.73164192 |
74 | DYRK1B | 0.72964175 |
75 | PDK2 | 0.72864766 |
76 | MAPKAPK3 | 0.72747604 |
77 | TIE1 | 0.71730155 |
78 | PRKG1 | 0.71640251 |
79 | EPHA3 | 0.70542579 |
80 | PRKACA | 0.70463464 |
81 | BRSK2 | 0.69401907 |
82 | CAMK1D | 0.68172968 |
83 | CAMK2G | 0.68126995 |
84 | MST4 | 0.68081683 |
85 | PRKAA1 | 0.67278666 |
86 | GSK3A | 0.66623331 |
87 | TNIK | 0.64479203 |
88 | TRPM7 | 0.61633652 |
89 | SGK3 | 0.61559941 |
90 | IRAK3 | 0.61107775 |
91 | PTK2 | 0.60454428 |
92 | NEK1 | 0.58906567 |
93 | PTK2B | 0.58733846 |
94 | FGFR3 | 0.56899940 |
95 | TGFBR2 | 0.56567114 |
96 | MAPK7 | 0.56451712 |
97 | MUSK | 0.56181451 |
98 | IKBKE | 0.54394948 |
99 | CSF1R | 0.53987439 |
100 | PDPK1 | 0.53404412 |
101 | STK38 | 0.52991064 |
102 | EPHA4 | 0.52304831 |
103 | PRKG2 | 0.51409726 |
104 | PRKCQ | 0.51293423 |
105 | STK3 | 0.51202041 |
106 | EIF2AK3 | 0.50214784 |
107 | GRK1 | 0.49954113 |
108 | MAP2K7 | 0.49921146 |
109 | CSNK1G1 | 0.46814465 |
110 | MAP2K1 | 0.46667264 |
111 | IKBKB | 0.46568673 |
112 | CSNK1A1 | 0.46250097 |
113 | RET | 0.45155127 |
114 | MAP3K13 | 0.44138836 |
115 | TAOK2 | 0.44020786 |
116 | CSNK1D | 0.43876234 |
117 | IGF1R | 0.43847506 |
118 | PRKCB | 0.42488225 |
119 | MAP3K5 | 0.41783008 |
120 | SGK2 | 0.40860069 |
121 | ICK | 0.39777358 |
122 | PRKACB | 0.39146701 |
123 | CDK4 | 0.38627660 |
124 | PBK | 0.37988838 |
125 | CAMK2A | 0.37877576 |
126 | TEC | 0.35089205 |
127 | PRKCG | 0.35060096 |
128 | MAP3K6 | 0.34439489 |
129 | MAP2K2 | 0.34394627 |
130 | PDK1 | 0.34350130 |
131 | PIK3CA | 0.33126551 |
132 | DYRK2 | 0.32537940 |
133 | MTOR | 0.32510937 |
134 | ERBB3 | 0.32088657 |
135 | MYLK | 0.31860059 |
136 | EGFR | 0.31289973 |
137 | MAP3K1 | 0.30840745 |
138 | CSNK1E | 0.29623819 |
139 | CAMK4 | 0.28827044 |
140 | PDK3 | 0.28452639 |
141 | PDK4 | 0.28452639 |
142 | PRKCA | 0.28427539 |
143 | SGK494 | 0.27561786 |
144 | SGK223 | 0.27561786 |
145 | CHUK | 0.27416321 |
146 | RPS6KA3 | 0.26696632 |
147 | MATK | 0.26458835 |
148 | CSNK1G2 | 0.26225167 |
149 | MAP3K2 | 0.25990117 |
150 | PKN1 | 0.24977743 |
151 | AKT3 | 0.24868149 |
152 | CSNK1G3 | 0.22078593 |
153 | BMX | 0.21790584 |
154 | PAK3 | 0.21471627 |
155 | ABL1 | 0.20249976 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.44265802 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.64958270 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.35153578 |
4 | * Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.23135819 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.08174695 |
6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.79575727 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.73957758 |
8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.69055643 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.60427063 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51788969 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50776069 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.38411640 |
13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.16037348 |
14 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14245391 |
15 | * Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.11725712 |
16 | Peroxisome_Homo sapiens_hsa04146 | 2.07874136 |
17 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.97486859 |
18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.97367957 |
19 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.95744369 |
20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.93276901 |
21 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.93092406 |
22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90073707 |
23 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.85316012 |
24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83244980 |
25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75235994 |
26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74435234 |
27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.73647681 |
28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.70715184 |
29 | * Retinol metabolism_Homo sapiens_hsa00830 | 1.62441481 |
30 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.62303416 |
31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.61161117 |
32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59336159 |
33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.57099943 |
34 | Bile secretion_Homo sapiens_hsa04976 | 1.56457637 |
35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52003284 |
36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.48224746 |
37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.41092750 |
38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.41020703 |
39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38067929 |
40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.37721775 |
41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29708571 |
42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.27365458 |
43 | ABC transporters_Homo sapiens_hsa02010 | 1.24282605 |
44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.24094704 |
45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23769086 |
46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20247102 |
47 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18891088 |
48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13587179 |
49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.03089845 |
50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02290298 |
51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01493326 |
52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00066537 |
53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93094991 |
54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90576529 |
55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89655434 |
56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87436502 |
57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.83752364 |
58 | Lysine degradation_Homo sapiens_hsa00310 | 0.82597625 |
59 | * Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78675173 |
60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72435537 |
61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.71767594 |
62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70488581 |
63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70258045 |
64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59187161 |
65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55074066 |
66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.50872291 |
67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49033326 |
68 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.46056012 |
69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30852767 |
70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27428669 |
71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26912564 |
72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26695330 |
73 | Prion diseases_Homo sapiens_hsa05020 | 0.24750948 |
74 | Insulin resistance_Homo sapiens_hsa04931 | 0.23479759 |
75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22057578 |
76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19977660 |
77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16654276 |
78 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.16492594 |
79 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.12953516 |
80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09636436 |
81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.04643196 |
82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02266031 |
83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.01922343 |
84 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.01880274 |
85 | Phototransduction_Homo sapiens_hsa04744 | 0.00437755 |
86 | Pertussis_Homo sapiens_hsa05133 | -0.2498009 |
87 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2463574 |
88 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2447401 |
89 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2221056 |
90 | Mineral absorption_Homo sapiens_hsa04978 | -0.2153174 |
91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1964000 |
92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1931811 |
93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1869138 |
94 | Hepatitis C_Homo sapiens_hsa05160 | -0.1750479 |
95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1632338 |
96 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1624243 |
97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1619991 |
98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1612209 |
99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1522536 |
100 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1398460 |
101 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1195731 |
102 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1042770 |
103 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1032041 |
104 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1025210 |
105 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0926335 |
106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.0830730 |
107 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0627547 |
108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0560655 |
109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0470856 |
110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0386611 |
111 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.0322752 |